These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24492935)
21. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Noma H; Funatsu H; Mimura T; Harino S; Hori S Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700 [TBL] [Abstract][Full Text] [Related]
22. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity. Sonmez K; Drenser KA; Capone A; Trese MT Ophthalmology; 2008 Jun; 115(6):1065-1070.e1. PubMed ID: 18031819 [TBL] [Abstract][Full Text] [Related]
23. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion. Noma H; Funatsu H; Mimura T; Eguchi S; Hori S Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846 [TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy. Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603 [TBL] [Abstract][Full Text] [Related]
25. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related]
26. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245 [TBL] [Abstract][Full Text] [Related]
27. Correlation between reflectivity of subretinal fluid in OCT images and concentration of intravitreal VEGF in eyes with diabetic macular edema. Sonoda S; Sakamoto T; Shirasawa M; Yamashita T; Otsuka H; Terasaki H Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5367-74. PubMed ID: 23860753 [TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy. Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544 [TBL] [Abstract][Full Text] [Related]
30. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY. Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446 [TBL] [Abstract][Full Text] [Related]
31. Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines. Funatsu H; Yamashita H; Mimura T; Noma H; Nakamura S; Hori S Eye (Lond); 2007 Mar; 21(3):377-82. PubMed ID: 16410812 [TBL] [Abstract][Full Text] [Related]
32. The effect of a systemic angiotensin receptor blocker on vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy. Byon IS; Jeon HS; Kim HW; Lee SJ; Lee JE; Oum BS Curr Eye Res; 2013 Jul; 38(7):774-80. PubMed ID: 23725216 [TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab. Ma Y; Zhang Y; Zhao T; Jiang YR Am J Ophthalmol; 2012 Feb; 153(2):307-313.e2. PubMed ID: 21982107 [TBL] [Abstract][Full Text] [Related]
35. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058 [TBL] [Abstract][Full Text] [Related]
36. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. Wells JA; Murthy R; Chibber R; Nunn A; Molinatti PA; Kohner EM; Gregor ZJ Br J Ophthalmol; 1996 Apr; 80(4):363-6. PubMed ID: 8703891 [TBL] [Abstract][Full Text] [Related]
37. Changes in foveal thickness after vitrectomy for macular edema with branch retinal vein occlusion and intravitreal vascular endothelial growth factor. Yamasaki M; Noma H; Funatsu H; Minamoto A; Mimura T; Shimada K; Yamashita H; Kiuchi Y Int Ophthalmol; 2009 Jun; 29(3):161-7. PubMed ID: 18797821 [TBL] [Abstract][Full Text] [Related]
38. Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment: report no. 1. Sohn EH; He S; Kim LA; Salehi-Had H; Javaheri M; Spee C; Dustin L; Hinton DR; Eliott D Arch Ophthalmol; 2012 Sep; 130(9):1127-34. PubMed ID: 22965588 [TBL] [Abstract][Full Text] [Related]
39. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema. Noma H; Funatsu H; Mimura T; Harino S; Eguchi S; Hori S Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1559-65. PubMed ID: 20714746 [TBL] [Abstract][Full Text] [Related]
40. Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy. Wei Q; Zhang T; Jiang R; Chang Q; Zhang Y; Huang X; Gao X; Jin H; Xu G Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5783-5791. PubMed ID: 29117316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]